Get the Stockscreener App
0.6008
1.56%
0.0092
After Hours:
.59
-0.0108
-1.80%
Rallybio Corp stock is traded at $0.6008, with a volume of 99,111.
It is up +1.56% in the last 24 hours and up +19.28% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.5916
Open:
$0.58
24h Volume:
99,111
Relative Volume:
0.04
Market Cap:
$25.11M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.328
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
-1.28%
1M Performance:
+19.28%
6M Performance:
-8.82%
1Y Performance:
-45.38%
1-Day Range:
$0.58
$0.6038
1-Week Range:
$0.5709
$0.63
52-Week Range:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.6008 | 25.07M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Can Rallybio Corporation rally from current levelsQuarterly Profit Summary & High Accuracy Investment Entry Signals - Newser
Is Rallybio Corporation stock dividend yield sustainableMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Rallybio Corporation stock prediction for this weekJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
Order flow analysis tools used on Rallybio CorporationJuly 2025 Institutional & Scalable Portfolio Growth Methods - Newser
Can swing trading help recover from Rallybio Corporation lossesWeekly Stock Recap & Weekly Breakout Watchlists - Newser
Using flow based indicators on Rallybio Corporation2025 Market Outlook & Long-Term Safe Return Strategies - Newser
Analyzing drawdowns of Rallybio Corporation with statistical toolsM&A Rumor & Low Risk Entry Point Tips - Newser
Chart based analysis of Rallybio Corporation trendsGlobal Markets & Fast Gain Stock Tips - Newser
Is Rallybio Corporation forming a bottoming base2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Is Rallybio Corporation stock ready for a breakout2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Detecting price anomalies in Rallybio Corporation with AIQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Will Rallybio Corporation rebound enough to break evenJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Rallybio: $12.5 Million Equity Milestone Payment Received - Pulse 2.0
What recovery options are there for Rallybio CorporationJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Applying Elliott Wave Theory to Rallybio CorporationTrend Reversal & High Conviction Trade Alerts - Newser
What moving averages say about Rallybio CorporationJuly 2025 Breakouts & Verified Entry Point Signals - Newser
Will breakout in Rallybio Corporation lead to full recoveryJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
Is Rallybio Corporation stock trending bullishJuly 2025 Snapshot & Low Drawdown Trading Techniques - Lancaster City Council
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN
Is Rallybio Corporation a top pick in the sectorEntry Point & AI Powered Buy and Sell Recommendations - beatles.ru
Will Breakout in Rallybio Corporation Sustain Through Next WeekTreasury Yields & Weekly High Return Stock Opportunities - beatles.ru
Can Rallybio Corporation disrupt its industryJuly 2025 Sector Moves & Short-Term Trading Opportunity Alerts - beatles.ru
Will Rallybio Corporation stock recover after earningsJuly 2025 Final Week & Weekly Return Optimization Alerts - beatles.ru
Traders Consider Averaging Down in Rallybio CorporationMarket Growth Summary & Real-Time Buy Signal Notifications - beatles.ru
Will Rallybio Corporation benefit from AI trends2025 Trade Ideas & AI Driven Stock Reports - beatles.ru
Can technical indicators confirm Rallybio Corporation’s reversal2025 Retail Activity & Reliable Volume Spike Trade Alerts - Newser
Will Rallybio Corporation see short term momentumEarnings Trend Report & Safe Capital Allocation Plans - Newser
Is Rallybio Corporation forming a bullish divergence2025 Market Outlook & Accurate Entry and Exit Point Alerts - خودرو بانک
Institutional scanner results for Rallybio CorporationMarket Volume Summary & Safe Capital Growth Trade Ideas - Newser
Rallybio Corporation shares rise 1.20% intraday after Morgan Stanley Global Healthcare Conference. - AInvest
Historical volatility pattern of Rallybio Corporation visualizedWeekly Risk Summary & Daily Technical Forecast Reports - Newser
What technical models suggest about Rallybio Corporation’s comebackJuly 2025 Review & Target Return Focused Picks - Newser
Can momentum traders help lift Rallybio CorporationJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Real time scanner hits for Rallybio Corporation explainedJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Using RSI to spot recovery in Rallybio CorporationGap Down & AI Powered Trade Plan Recommendations - Newser
Rallybio receives $12.5M equity milestone payment - Hartford Business Journal
Rallybio receives milestone payment as REV-10 advances - BioWorld MedTech
How to interpret RSI for Rallybio Corporation stockGap Up & Free Fast Entry Momentum Trade Alerts - Newser
Rallybio shares rise 5.19% premarket after receiving $12.5 million equity milestone payment from Recursion. - AInvest
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program - BioSpace
Rallybio Corporation stock volume spike explainedJuly 2025 Retail & Accurate Trade Setup Notifications - Newser
How to integrate Rallybio Corporation into portfolio analysis toolsProduct Launch & Low Drawdown Momentum Trade Ideas - Newser
Price action breakdown for Rallybio Corporation2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Rallybio receives $12.5M equity milestone payment from Recursion Pharmaceuticals - MSN
Rallybio shares fall 3.11% after-hours despite receiving $12.5 million equity milestone payment from Recursion. - AInvest
Can Rallybio Corporation scale operations efficiently2025 Winners & Losers & Community Consensus Trade Signals - خودرو بانک
What is the PEG ratio of Rallybio CorporationEarnings Recap Report & AI Forecasted Entry and Exit Points - خودرو بانک
Can Rallybio Corporation be the next market leaderMarket Performance Report & Verified Momentum Stock Watchlist - خودرو بانک
Rallybio Receives $12.5 Million Equity Milestone From Recursion - MarketScreener
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):